New Research at ESMO 2025 Boosts Potential of Blood Tests in Cancer Treatment Guidance

Recent data presented at ESMO 2025 strengthens the evidence that novel blood tests can assist doctors in determining which cancer patients require additional therapy and which patients may avoid further treatment.